
Iracet500 mg
Square Pharmaceuticals PLC.
Levetiracetam is a broad-spectrum antiepileptic drug used in the treatment of several seizure types, either alone or together with other antiseizure medicines.
Levetiracetam is a broad-spectrum antiepileptic drug used in the treatment of several seizure types, either alone or together with other antiseizure medicines. Indications are classified below by strength of evidence.
The decision to use Levetiracetam for a particular seizure type should be individualized by a treating physician based on seizure classification and patient factors.
| Indication | Population | Dosing |
|---|---|---|
| Partial-onset seizures (monotherapy) | Adults & adolescents ≥16 years | Start 500 mg twice daily; may increase every 2 weeks by 500 mg twice daily to a maximum of 1500 mg twice daily |
| Partial-onset seizures (adjunctive) | Adults | Start 500 mg twice daily; increase by 500 mg twice daily every 2 weeks as needed, maximum 1500 mg twice daily |
| Partial-onset seizures (adjunctive) | Children 1 month - <16 years | Weight-based dosing starting at 7-10 mg/kg twice daily, titrated gradually to a maximum of 21-30 mg/kg twice daily depending on age; a physician/pediatric neurologist must individualize this |
| Myoclonic seizures (adjunctive) | Patients ≥12 years | Start 500 mg twice daily; may increase by 500 mg twice daily every 2 weeks up to 1500 mg twice daily |
| Primary generalized tonic-clonic seizures (adjunctive) | Patients ≥6 years (weight-based in children) | Similar titration schedule as above, individualized by weight in children |
| Creatinine Clearance | Dose |
|---|---|
| >80 mL/min | 500-1500 mg every 12 hours |
| 50-79 mL/min | 500-1000 mg every 12 hours |
| 30-49 mL/min | 250-750 mg every 12 hours |
| <30 mL/min | 250-500 mg every 12 hours |
| Hemodialysis patients | 500-1000 mg once daily, plus a supplemental dose of 250-500 mg after each dialysis session |
Levetiracetam must never be stopped abruptly (see Precautions). All doses above should be adjusted or confirmed by the prescribing physician.
| Population | Common Adverse Effects |
|---|---|
| Adults | Somnolence, asthenia (weakness/fatigue), infection, dizziness, headache, irritability |
| Children | Fatigue, aggression, nasal congestion, decreased appetite, irritability, behavioral changes |
Patients should seek prompt medical attention for any rash, swelling, breathing difficulty, or unusual bleeding/bruising.
Levetiracetam is contraindicated in patients with known hypersensitivity to levetiracetam, to other pyrrolidone derivatives, or to any excipient in the formulation. Hypersensitivity reactions including anaphylaxis and angioedema have been reported.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.